103 related articles for article (PubMed ID: 26387966)
1. Effect of cisplatin on proteasome activity.
Tundo GR; Sbardella D; Ciaccio C; De Pascali S; Campanella V; Cozza P; Tarantino U; Coletta M; Fanizzi FP; Marini S
J Inorg Biochem; 2015 Dec; 153():253-258. PubMed ID: 26387966
[TBL] [Abstract][Full Text] [Related]
2. Lactacystin enhances cisplatin sensitivity in resistant human ovarian cancer cell lines via inhibition of DNA repair and ERCC-1 expression.
Li QQ; Yunmbam MK; Zhong X; Yu JJ; Mimnaugh EG; Neckers L; Reed E
Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL61-72. PubMed ID: 11936875
[TBL] [Abstract][Full Text] [Related]
3. Separation of cathepsin A-like enzyme and the proteasome: evidence that lactacystin/beta-lactone is not a specific inhibitor of the proteasome.
Ostrowska H; Wójcik C; Wilk S; Omura S; Kozlowski L; Stoklosa T; Worowski K; Radziwon P
Int J Biochem Cell Biol; 2000 Jul; 32(7):747-57. PubMed ID: 10856705
[TBL] [Abstract][Full Text] [Related]
4. Proteasome inhibitor lactacystin enhances cisplatin cytotoxicity by increasing endoplasmic reticulum stress-associated apoptosis in HeLa cells.
Xu Y; Li D; Zeng L; Wang C; Zhang L; Wang Y; Yu Y; Liu S; Li Z
Mol Med Rep; 2015 Jan; 11(1):189-95. PubMed ID: 25323748
[TBL] [Abstract][Full Text] [Related]
5. Prevention of cisplatin-DNA adduct repair and potentiation of cisplatin-induced apoptosis in ovarian carcinoma cells by proteasome inhibitors.
Mimnaugh EG; Yunmbam MK; Li Q; Bonvini P; Hwang SG; Trepel J; Reed E; Neckers L
Biochem Pharmacol; 2000 Nov; 60(9):1343-54. PubMed ID: 11008128
[TBL] [Abstract][Full Text] [Related]
6. Proteasome inhibition correlates with intracellular bortezomib concentrations but not with antiproliferative effects after bolus treatment in myeloma cell lines.
Dettmer S; Theile D; Schäfer J; Seckinger A; Burhenne J; Weiss J
Naunyn Schmiedebergs Arch Pharmacol; 2016 Oct; 389(10):1091-101. PubMed ID: 27422413
[TBL] [Abstract][Full Text] [Related]
7. Stereospecific total syntheses of proteasome inhibitors omuralide and lactacystin.
Gu W; Silverman RB
J Org Chem; 2011 Oct; 76(20):8287-93. PubMed ID: 21916437
[TBL] [Abstract][Full Text] [Related]
8. Lactacystin, a proteasome inhibitor, potentiates the apoptotic effect of parthenolide, an inhibitor of NFkappaB activation, on drug-resistant mouse leukemia L1210 cells.
Cory AH; Cory JG
Anticancer Res; 2002; 22(6C):3805-9. PubMed ID: 12552998
[TBL] [Abstract][Full Text] [Related]
9. Combined effect of proteasome and calpain inhibition on cisplatin-resistant human melanoma cells.
Młynarczuk-Biały I; Roeckmann H; Kuckelkorn U; Schmidt B; Umbreen S; Gołab J; Ludwig A; Montag C; Wiebusch L; Hagemeier C; Schadendorf D; Kloetzel PM; Seifert U
Cancer Res; 2006 Aug; 66(15):7598-605. PubMed ID: 16885359
[TBL] [Abstract][Full Text] [Related]
10. Effects of tau phosphorylation on proteasome activity.
Ren QG; Liao XM; Chen XQ; Liu GP; Wang JZ
FEBS Lett; 2007 Apr; 581(7):1521-8. PubMed ID: 17376439
[TBL] [Abstract][Full Text] [Related]
11. Cooperative cytotoxicity of proteasome inhibitors and tumor necrosis factor-related apoptosis-inducing ligand in chemoresistant Bcl-2-overexpressing cells.
Nencioni A; Wille L; Dal Bello G; Boy D; Cirmena G; Wesselborg S; Belka C; Brossart P; Patrone F; Ballestrero A
Clin Cancer Res; 2005 Jun; 11(11):4259-65. PubMed ID: 15930365
[TBL] [Abstract][Full Text] [Related]
12. Antitumorigenic effect of proteasome inhibitors on insulinoma cells.
Størling J; Allaman-Pillet N; Karlsen AE; Billestrup N; Bonny C; Mandrup-Poulsen T
Endocrinology; 2005 Apr; 146(4):1718-26. PubMed ID: 15618349
[TBL] [Abstract][Full Text] [Related]
13. Proteasome inhibitor lactacystin augments natural killer cell cytotoxicity of myeloma via downregulation of HLA class I.
Wu X; Shao Y; Tao Y; Ai G; Wei R; Meng X; Hou J; Han Y; Zhan F; Zheng J; Shi J
Biochem Biophys Res Commun; 2011 Nov; 415(1):187-92. PubMed ID: 22033416
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effect between proteasome and autophagosome in the clearance of polyubiquitinated TDP-43.
Urushitani M; Sato T; Bamba H; Hisa Y; Tooyama I
J Neurosci Res; 2010 Mar; 88(4):784-97. PubMed ID: 19798749
[TBL] [Abstract][Full Text] [Related]
15. The proteasome and intracellular redox status: implications for apoptotic regulation in lens epithelial cells.
Petersen A; Carlsson T; Karlsson JO; Zetterberg M
Curr Eye Res; 2007 Oct; 32(10):871-82. PubMed ID: 17963107
[TBL] [Abstract][Full Text] [Related]
16. Effect of ajoene, a natural antitumor small molecule, on human 20S proteasome activity in vitro and in human leukemic HL60 cells.
Xu B; Monsarrat B; Gairin JE; Girbal-Neuhauser E
Fundam Clin Pharmacol; 2004 Apr; 18(2):171-80. PubMed ID: 15066131
[TBL] [Abstract][Full Text] [Related]
17. Activation of Chymotrypsin-Like Activity of the Proteasome during Ischemia Induces Myocardial Dysfunction and Death.
Sanchez G; Berrios D; Olmedo I; Pezoa J; Riquelme JA; Montecinos L; Pedrozo Z; Donoso P
PLoS One; 2016; 11(8):e0161068. PubMed ID: 27529620
[TBL] [Abstract][Full Text] [Related]
18. Preservation of caspase-3 subunits from degradation contributes to apoptosis evoked by lactacystin: any single lysine or lysine pair of the small subunit is sufficient for ubiquitination.
Chen L; Smith L; Wang Z; Smith JB
Mol Pharmacol; 2003 Aug; 64(2):334-45. PubMed ID: 12869638
[TBL] [Abstract][Full Text] [Related]
19. Lactacystin, a specific inhibitor of the proteasome, inhibits human platelet lysosomal cathepsin A-like enzyme.
Ostrowska H; Wojcik C; Omura S; Worowski K
Biochem Biophys Res Commun; 1997 May; 234(3):729-32. PubMed ID: 9175783
[TBL] [Abstract][Full Text] [Related]
20. Proteasome inhibitor lactacystin ablates liver injury induced by intestinal ischaemia-reperfusion.
Yao JH; Li YH; Wang ZZ; Zhang XS; Wang YZ; Yuan JC; Zhou Q; Liu KX; Tian XF
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1102-8. PubMed ID: 17880361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
